| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | -45.2% | -58.9% |
| Cost of Revenue | $574K | -6.6% | -19.7% |
| Gross Profit | $604K | -60.6% | -72.0% |
| R&D Expense | $753K | +1.7% | -29.8% |
| SG&A Expense | $2.7M | -3.4% | +1.9% |
| Operating Income | -$2.9M | -41.8% | -80.6% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.8M | -8.7% | -11.7% |
| Accounts Receivable | $1.2M | — | — |
| Current Assets | $7.0M | -21.1% | -12.2% |
| Total Assets | $8.1M | -19.6% | -10.9% |
| Current Liabilities | $5.5M | -0.4% | -31.5% |
| Total Liabilities | $48.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | — |
| Financing Cash Flow | -$1.1M | — | — |
| — |
| Net Income | $6.4M | +127.0% | +3.2% |
| EPS (Basic) | $0.20 | +126.7% | -20.0% |
| EPS (Diluted) | $0.15 | +120.0% | -11.8% |
| -15.4% |
| +118.8% |
| Stockholders' Equity | -$40.1M | +14.5% | -210.2% |